TP53 and neoplasm: It has therefore been postulated that drugs that can restore wt TP53 transcriptional activities in human tumour cells expressing mutant TP53 would cause cell proliferation arrest, cellular senescence and/or apoptotic cell death with consequent therapeutic benefit.